EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

08.09.17

When It Comes to Software Patents, the EPO Has Become Among the Worst in the World

Posted in America, Asia, Europe at 3:20 pm by Dr. Roy Schestowitz

CII at EPO
This EPO presentation spoke of software patents (“CII”). Photo credit: EPO Patent Information Conference 2016 (Grant Philpott)

Summary: Software patents, which were never meant to be granted by the EPO, are nowadays being granted quite leniently and easily (whereas other patent offices growingly reject these, deeming them too abstract and not beneficial)

THE EPO does not seem to mind the law (or any of the laws). It exists in a vacuum and it grants software patents in Europe in defiance of directives, the public interest, and the EPC.

Earlier today Graham McGlashan from Marks & Clerk said that a “computer program itself can potentially be patented at the European Patent Office” because the EPO has gone rogue and the subject isn’t even up for debate anymore; the EPO promotes these patents in public events and by doing so it metaphorically spits at the Parliament, at the European public, and on the EPC.

Here is the relevant paragraph:

The European Patent Office will potentially allow a patent if the claimed subject matter is novel and inventive and has a technical character – even if the invention is computer implemented. A computer program itself can potentially be patented at the European Patent Office if it is capable of bringing about, when running on a computer, a further technical effect going beyond the “normal” physical interactions between the program (software) and the computer (hardware) on which it is run.

This was published by people who put misleading puff pieces in British media and promote software patents, the UPC etc.

The above is of course the old mumbo-jumbo where general-purpose computers on which programs run are used to attribute some magical physical properties to code. It’s a clever trick, but it’s all just a sham. Yet it helps bypass examiners.

Several months ago Marks & Clerk said in a public event that it had become easier to patent software at the EPO than at the USPTO. How revealing a statement!

Looking elsewhere in the news today, IAM published another marketing piece (this one for Bereskin & Parr LLP) with nothing in it about patent scope as CIPO (Canada’s patent office) is having a consultation and there’s no sign of growing tolerance towards software patents. Innofy’s Katherine Rock wrote about software patents in Australia, taking stock of quite a few recent cases and concluding that “Australian Patent Office Says No” (to software patents).

From the concluding part:

On the face of it, the decision issued in July by the Australian Patent Office may be discouraging as the apparent rejections relate to a broad range of fields of innovation – from collection and analysis of data, targeting advertising, statistical optimisation for assay analysis, and insurance policy management.

However, it does appear that the Patent Office is operating on a case by case basis, and in addition looking to authorities which ostensibly require a demonstrable technical effect (see, eg, Aerotel), a concrete, physical effect (see, eg, Grant), and/or distinctions from a generic computer system(s). Therefore, we would advise that when seeking to apply for patent protection in Australia, you consider these authorities and seek a professional opinion – so feel free to contact us with any questions.

Notwithstanding the above, given the contention around the issue of patent eligibility of software, and the fact that the interpretation of the Patents Act may be subject to change as more cases are brought before the courts, we could well see a relaxing (or tightening) of these requirements in years to come.

Is it harder to get software patents in Australia than it is in Europe? Remember that in the US even if one manages to get a software patent, this patent is very unlikely to be upheld in courts. We have heard that the same is becoming true in Japan (the only other stronghold of software patents*). These patents just lack potency and would be worthless if asserted, which is why patent trolls prefer going after small firms which would settle out of court.

Earlier today we spotted this announcement about purchase [sic] (reassignment) of patents that are basically on software but are painted as “mobile” (to bypass abstractness tests). Here are the patents:

USPTO 8,369,828 “Mobile-to-Mobile Payment System and Method”;
USPTO 8,073,895 & 8,572,166 “System and Method for Delivering Web Content to a Mobile Device”;
USPTO 8,315,184 “Computer to Mobile Two-Way Chat System and Method”

This seems like a waste of time and money. Maybe they just didn’t get the ‘memo’ about software patents in the US.

So how did the EPO become a laughing stock for low patent quality? (or broad scope)

Part of the problem, we suspect, is Battistelli's attack on the Boards of Appeal of the European Patent Office (BoA), which exist to help guard — independently — the integrity and quality of the EPO. “In Decision T 488/16,” we learned today, BoA “have revoked EP 1 169 038…”

Here are the details:

In Decision T 488/16, the Boards of Appeal of the European Patent Office (BoA) have revoked EP 1 169 038, which protected the blockbuster protein tyrosine kinase (PTK) inhibitor dasatinib (Sprycel®). The only request on file — a single claim directed to dasatinib per se or a salt thereof — was found to lack inventive step in view of the absence of evidence in the application as filed (and the common general knowledge) which rendered the activity of dasatinib in inhibiting PTK “plausible”. A general statement in the application as filed that “Compounds described in the following Examples have been tested in one or more of these assays, and have shown activity” was not by itself considered enough to render it credible to the skilled person that the described compounds were PTK inhibitors. In the absence of a plausible disclosure of activity against PTK in the specification as filed, the objective technical problem was defined by the Board of Appeal as merely “the provision of a further chemical compound”. The extensive clinical data which became available after the filing date of the patent evidencing biological activity was not taken into account when determining inventive step.

The Boards of Appeal of the European Patent Office have for many years imposed a requirement that claims for large molecules (e.g., proteins) must be supported by a plausible disclosure of biological activity in the application as filed (see, for example, T 1329/04). A similar requirement for a plausible disclosure of activity in the original specification has also been required to support medical use claims (see, for example, T 0609/02). However, this Decision indicates that the Boards are willing to apply the same strict standards when assessing claims for small molecule drugs per se.

Based on recent reports, the BoA may already be ‘in transit’, having been exiled by Battistelli with help from Kongstad (who will be leaving the EPO next month). We are very worried that the EPO without a strong and independent BoA will take the European patent regime into total oblivion.
_____
* Japan has long been known as the ‘twin’ of the US when it comes to software patents, with Korea highly reluctant to follow suit and only China relaxing the rules as it opens the floodgates to just about any patent (not just on software).

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. Index for EPO and Saint-Germain's Poisonous Legacy of "Toxic Loans" Series

    A roundup or an index of this past week's series about financial gambles at the EPO -- Battistelli's own dubious idea



  2. Saint-Germain's Poisonous Legacy of "Toxic Loans": Quo Vadis EPO?

    In spite of the SIDRU “toxic loans” scandal in St. Germain-en-Laye, where Battistelli is Deputy Mayor, the EPO’s Administrative Council repeats similar mistakes with opposition only from one country — the only country that actually bothered to study the matter before voting on it



  3. Links 26/5/2018: Wine 3.9, KStars 2.9.6, Bodhi 3.8.0, FreeBSD 11.2 Beta 3

    Links for the day



  4. Saint-Germain's Poisonous Legacy of "Toxic Loans": The SIDRU “Toxic Loan” Débâcle a Case of “Take the Money and Run...”

    The fourth part of the series exploring the debt crisis at Battistelli’s town (where he’s deputy mayor) in light of the EPO’s gambling with financial speculators, potentially adding to the many EPO scandals



  5. EPO, a Longtime Privacy Offender, Uses General Data Protection Regulation (GDPR) Day to Lie to the Public

    The European Patent Office (EPO) has the nerve to pretend to value privacy after all it has done; it's just exploiting the "GDPR Day" buzz to spread some more face-saving lies about the very subject it has become incredibly notorious for



  6. The Unitary Patent and the Unified Patent Court (UPC): This Week's Latest Spin and Lies

    The EPO has adopted a largely passive approach, choosing barely to comment at all on the UPC whereas Team UPC keeps repeating the same misleading if not patently untrue claims to perpetuate the notion that UPC is inevitable



  7. Links 25/5/2018: OpenSUSE 15 Leap Released, PostgreSQL 11 Beta

    Links for the day



  8. Privacy Statement

    Today, May 25th, the European General Data Protection Regulation (GDPR) goes into full effect; we hereby make a statement on privacy



  9. Saint-Germain's Poisonous Legacy of "Toxic Loans": The SIDRU “Toxic Loan” Débâcle and Criticism of Lamy From Local Opposition Groups

    The EPO‘s entrance into the “toxic loans” trap as of a few months back (just like in Saint-Germain) is a sign of potential trouble ahead; The SIDRU “toxic loan” débâcle is highlighted as per criticism of mayor Lamy (St Germain-en-Laye, where Battistelli is deputy mayor) from local opposition groups



  10. New EPO Caricature: The Rubber Stamp

    Cartoon which circulates in EPO 'circles', encapsulating the concern many people have about the quality of granted patents and unrealistic expectations from the management



  11. Links 24/5/2018: RIP Robin “Roblimo” Miller, Qt 5.11 Released

    Links for the day



  12. Walmart, Bank of America, Allied Security Trust (AST) and the Rush for 'Blockchain' Patents

    The hoarding of patents on novel-sounding code has reached ridiculous levels; very large corporations and even patent trolls arm themselves with such patents, hoping to make returns by means of litigation or an 'arms trade'



  13. Stupid Blogs, Stupid Lawsuits, and Stupid Patents

    The stupidity of the patent microcosm, which would like to see everything in the world patented and which would gleefully smear or even sue its critics (the EFF was sued several times for libel over its "Stupid Patent of the Month" series)



  14. Perpetuating the Big Lie That Unitary Patent (UPC) is About to Kick Off

    The (in)famous old lie about UPC being "just around the corner" is still being circulated, mainly if not only by patent law firms which stand to benefit from a litigation Armageddon in Europe



  15. EPO Validation in Former French Colonies That Have Zero European Patents

    The strategy of the EPO seems to be centered around the interests of Benoît Battistelli and his political career rather than that of the EPO; validation deals and dubious 'Inventor Awards' seem to be part of this pattern



  16. Saint-Germain's Poisonous Legacy of "Toxic Loans": The Cautionary Tale of SIDRU and Its “Toxic Loans”

    The town where the EPO‘s President (Battistelli) is a deputy mayor has a track record of financial hardship and alleged financial misconduct, attributed to the same financial practices Battistelli has just implemented at the EPO



  17. Links 23/5/2018: DragonFlyBSD 5.2.1 and Kata Containers 1.0 Released

    Links for the day



  18. Masking Abstract Patents in the Age of Alice/§ 101 in the United States

    There are new examples and ample evidence of § 101-dodging strategies; the highest US court, however, wishes to limit patent scope and revert back to an era of patent sanity (as opposed to patent maximalism)



  19. PTAB's Latest Applications of 35 U.S.C. § 101 and Obviousness Tests to Void U.S. Patents

    Validity checks at PTAB continue to strike out patents, much to the fear of people who have made a living from patenting and lawsuits alone



  20. France is Irrelevant to Whether or Not UPC Ever Becomes a Reality, Moving/Outsourcing de Facto Patent Examination to European Courts Managed in/Presided by France

    Team UPC is still focusing on France as if it's up for France to decide the fate of the UPC, which EPO insiders say Battistelli wants to be the chief of (the chief, it has already been decided, would have to be a Frenchman)



  21. Saint-Germain's Poisonous Legacy of "Toxic Loans": The Emperor’s New Investment Guidelines

    Details about a secret vote to 'gamble' the EPO's budget on "a diversified portfolio managed by external experts"



  22. Saint-Germain's Poisonous Legacy of "Toxic Loans": Cautionary Tale for the EPO?

    Preface or background to a series of posts about Battistelli's French politics and why they can if not should alarm EPO workers



  23. Links 22/5/2018: Parrot 4.0, Spectre Number 4

    Links for the day



  24. Chamber of Commerce Lies About the United States Like It Lies About Other Countries for the Sole Purpose of Patent Maximalism

    When pressure groups that claim to be "US" actively bash and lie about the US one has to question their motivation; in the case of the Chamber of Commerce, it's just trying to perturb the law for the worse



  25. Links 21/5/2018: Linux 4.17 RC6, GIMP 2.10.2

    Links for the day



  26. The Attacks on the Patent Trial and Appeal Board (PTAB) Have Lost Momentum and the Patent Microcosm Begrudgingly Gives Up

    The Patent Trial and Appeal Board (PTAB), reaffirmed by the Court of Appeals for the Federal Circuit (CAFC) and now the Supreme Court as well, carries on preventing frivolous lawsuits; options for stopping PTAB have nearly been exhausted and it shows



  27. Software Patenting and Successful Litigation a Very Difficult Task Under 35 U.S.C. § 101

    Using loads of misleading terms or buzzwords such as "AI" the patent microcosm continues its software patents pursuits; but that's mostly failing, especially when courts come to assess pertinent claims made in the patents



  28. António Campinos Will Push Toward a France-Based Unified Patent Court (UPC)

    Frenchmen at EPO will try hard to bring momentum if not force to the Unified Patent Court; facts, however, aren't on their side (unlike Team UPC, which was always on Team Battistelli's side)



  29. In Apple v Samsung Patents That Should Never Have Been Granted May Result in a Billion Dollars in 'Damages'

    A roundup of news about Apple and its patent cases (especially Apple v Samsung), including Intel's role trying to intervene in Qualcomm v Apple



  30. Links 20/5/2018: KDevelop 5.2.2 and 5.2.3, FreeBSD 11.2 Beta 2

    Links for the day


CoPilotCo

RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

CoPilotCo

Recent Posts